- Home
- CDXS vs PHLT Comparison
CDXS vs PHLT Comparison
Compare CDXS & PHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- PHLT
- Stock Information
- Founded
- CDXS 2002
- PHLT 1976
- Country
- CDXS United States
- PHLT United States
- Employees
- CDXS N/A
- PHLT N/A
- Industry
- CDXS Major Chemicals
- PHLT Other Consumer Services
- Sector
- CDXS Industrials
- PHLT Consumer Discretionary
- Exchange
- CDXS Nasdaq
- PHLT Nasdaq
- Market Cap
- CDXS 230.3M
- PHLT 187.1M
- IPO Year
- CDXS 2010
- PHLT N/A
- Fundamental
- Price
- CDXS $2.81
- PHLT $3.00
- Analyst Decision
- CDXS Buy
- PHLT
- Analyst Count
- CDXS 2
- PHLT 0
- Target Price
- CDXS $11.00
- PHLT N/A
- AVG Volume (30 Days)
- CDXS 1.1M
- PHLT 145.2K
- Earning Date
- CDXS 05-01-2025
- PHLT 03-12-2025
- Dividend Yield
- CDXS N/A
- PHLT N/A
- EPS Growth
- CDXS N/A
- PHLT N/A
- EPS
- CDXS N/A
- PHLT N/A
- Revenue
- CDXS $59,345,000.00
- PHLT $122,981,000.00
- Revenue This Year
- CDXS $14.56
- PHLT $11.53
- Revenue Next Year
- CDXS $21.41
- PHLT N/A
- P/E Ratio
- CDXS N/A
- PHLT N/A
- Revenue Growth
- CDXS N/A
- PHLT 8.12
- 52 Week Low
- CDXS $2.43
- PHLT $2.26
- 52 Week High
- CDXS $6.08
- PHLT $4.35
- Technical
- Relative Strength Index (RSI)
- CDXS 42.35
- PHLT N/A
- Support Level
- CDXS $2.43
- PHLT N/A
- Resistance Level
- CDXS $3.04
- PHLT N/A
- Average True Range (ATR)
- CDXS 0.22
- PHLT 0.00
- MACD
- CDXS 0.08
- PHLT 0.00
- Stochastic Oscillator
- CDXS 51.35
- PHLT 0.00
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About PHLT Performant Healthcare Inc. Common Stock
Performant Healthcare Inc delivers payment integrity solutions for its healthcare payer clients.